Clinical trial
Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034
NCT00478725 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00478725 |
|---|---|
| Title | Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 |
| Official title | An Open-Label, Two-Part Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of Pazopanib (GW786034) and the Absorption, Distribution, Metabolism and Elimination of a Single Oral [14C] Labeled Dose of Pazopanib in Subjects With Solid Tumor Malignancies |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma, Renal Cell |
| Intervention type | Drug |
| Interventions | GW786034, oral, IV, radiolabeled oral |
| Enrollment | 10 |
| Start date | Jul 18, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | May 25, 2007 |
| Last update posted | Nov 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: